Skip to main content
Log in

Altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression and regulation in mouse fibroblasts transformed with oncogenes or constitutively active Mitogen-Activated Protein (MAP) kinase kinase

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

In the present study, the expression and the regulation of ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (SAMDC) was examined in a series of oncogene transformed cell lines. The expression of both ODC and SAMDC was found to correlate with the nature of the oncogene expressed and with the resulting cellular phenotype expressed. This study demonstrates, for the first time, that the expression of both ODC and SAMDC increases as a function of cellular transformation and, in particular, as a function of malignant progression. Ras transformed cells were shown to express a unique regulatory mechanism whereby a co-ordinate up-regulation of the expression of both ODC and SAMDC occurs (via post-transcriptional stabilization of their mRNA transcripts) in the presence of protein synthesis inhibition. Altered expression (and regulation) of both ODC and SAMDC is suggested to constitute an important part of an altered growth regulatory program inherent to oncogene transformed cells, in particular, to transformed cells capable of malignant progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tabor H, Tabor CW: Polyamines. In: C.H. Richardson, P.D. Boyer, A. Meister (eds). Ann Rev Biochem, Annual Reviews Inc., Palo alto, CA, 53: 749–790, 1984

    Google Scholar 

  2. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759–774, 1988

    Google Scholar 

  3. Heby O, Persson L: Molecular genetics of polyamine biosynthesis in eukaryotic cells. Trends Biochem Sci 15: 153–158, 1990

    Google Scholar 

  4. Janne J, Alhonen L, Leinonen P: Polyamines: From molecular biology to clinical application. Ann Med 23: 241–259, 1991

    Google Scholar 

  5. Marton LJ, Pegg AE: Polyamines as targets for chemotherapeutic intervention. In: A.K. Cho, T.F. Blaschke, H.H. Loh, J.L. Way (eds). Ann Rev Pharmacol Toxicol, Annual Reviews Inc., Palo Alto, CA, 35: 55–91, 1995

    Google Scholar 

  6. McCann PP, Pegg AE: Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther 54: 195–215, 1992

    Google Scholar 

  7. Pegg AE, McCann PP: S-adenoslymethionine decarboxylase as an enzyme target for therapy. Pharmacol Ther 56: 359–377, 1992

    Google Scholar 

  8. Pegg AE: Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 243: 249–262, 1986

    Google Scholar 

  9. Pegg AE, McCann PP: Polyamine metabolism and function. Am J Physiol 243: 212–221, 1982

    Google Scholar 

  10. Suorsa A, Hietala O, Pajunen A: Developmental expression of ornithine and S-adenoslymethionine decarboxylases in mouse brain. Biochem Biophys Res Commun 184: 2, 1992

    Google Scholar 

  11. Hurta RAR, Huang A, Wright JA: Basic fibroblast growth factor selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed cells. J Cell Biochem 60: 572–583, 1996

    Google Scholar 

  12. de Bustros A, Baylin SB, Berger CL, Roos BA, Leong SS, Nelkin BD: Phorbol esters increase calcitonin gene transcription and decrease cmyc mRNA levels in cultured human medullary thyroid carcinoma. J Biol Chem 260: 98–104, 1985

    Google Scholar 

  13. McNight GS, Monroe JG: Role of primary response genes in generating cellular response to growth factors. FASEB J 6: 2707–2715, 1992

    Google Scholar 

  14. Patel AR, Li J, Bass BL, Wang J-Y: Expression of the transforming growth factor beta gene during growth inhibition following polyamine depletion. Am J Physiol: 590–598, 1998

  15. Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro L, Hager G, Greenberg AH: Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10 T1/2 and NIH-3T3 cells. Mol Cell Biochem 7: 830–837, 1987

    Google Scholar 

  16. Turley EA, Austen L, Vandeligt K, Clary C: Hyaluronan and a cell associated hyaluronan binding protein regulate the locomotion of ras transformed cells. J Cell Biol 112: 1041–1047, 1991

    Google Scholar 

  17. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966–979, 1994

    Google Scholar 

  18. Paasinen-Sohns A, Holtta E: Cells transformed with ODC, c-Ha-ras, and v-src exhibit MAP kinase/Erk independent constitutive phosphorylation of Sos, Raf, and c-Jun activation domain, and reduced PDGF receptor expression. Oncogene 15: 1953–1966, 1997

    Google Scholar 

  19. Flamigni F, Facchini A, Capanni C, Stefanelli C, Tantini B, Caldarera CM: p44/42 mitogen activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells. Biochem J 341: 363–369, 1999

    Google Scholar 

  20. Manni A, Wechter R, Gilmour S, Verderame MF, Mauger D, Demers LM: Ornithine decarboxylase over-expression stimulates mitogenactivated protein kinase and anchorage independent growth of human breast epithelial cells. Int J Cancer 70: 175–182, 1997

    Google Scholar 

  21. Chiao PJ, Kannan P, Yim SO, Krizman DB, Wu T-A, Gallick GE, Tainsky MA: Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors. Oncogene 6: 713–720, 1991

    Google Scholar 

  22. Shayovits A, Bachrach U: Ornithine decarboxylase: An indicator for growth of NIH-3T3 fibroblasts and their c-Ha-ras transformants. Biochim Biophys Acta 1267: 107–114, 1995

    Google Scholar 

  23. Sistonen L, Keski-Oja J, Ulmanen I, Hollta E, Wikgren B-J, Alitalo K: Dose effects of transfected c-Ha-ras Vas 12 oncogene in transformed cell clones. Exp Cell Res 168: 518–530, 1987

    Google Scholar 

  24. Shantz LM, Pegg AE: Ornithine decarboxylase induction in transformation by H-ras and RhoA. Cancer Res 58: 2748–2753, 1998

    Google Scholar 

  25. Hollta E, Sistonen L, Alitalo K: The mechanism of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J Biol Chem 263: 4500–4507, 1988

    Google Scholar 

  26. Trimble WS, Johnson PW, Hozumi N, Roder JC: Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility. Nature 321: 782–784, 1986

    Google Scholar 

  27. Egan SE, Wright JA, Jarolim L, Yanagihara K, Bassin RH, Greenberg AH: Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238: 202–205, 1987

    Google Scholar 

  28. Egan SE, Jarolim L, Rogelj S, Spearman M, Wright JA, Greenberg AH: Growth factor modulation of metastatic lung colonization. Anticancer Res 10: 1391–1346, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hurta, R.A. Altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression and regulation in mouse fibroblasts transformed with oncogenes or constitutively active Mitogen-Activated Protein (MAP) kinase kinase. Mol Cell Biochem 215, 81–92 (2000). https://doi.org/10.1023/A:1026539414863

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026539414863

Navigation